Puma Biotechnology, Inc.
Puma Biotechnology, Inc.（PBYI）股价预测与分析师目标价
华尔街共识、12 个月目标价、模型推演与 EPS/营收预期 — 来自分析师数据与历史行情。
pbyi · 股价预测 · 19 位分析师（近3月）· FMP · 更新于 2026年6月8日
分析师评级与共识
基于过去 3 个月内 19 位华尔街分析师
Buy
19 位分析师
共识
评级分布
12 个月目标价
High
$0.00
Consensus
$0.00
+0.0% upside
Low
$0.00
Median: $0 · Last Close: $6.85
短期股价预测
算法生成 · 每日更新
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $6.77 | ↓ 1.16% |
1-day model range: $6.75–$6.79. Peak: $6.79 (-1.16%).
长期股价预测
年度股价预测 · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $8 | +20.9% |
| 2028 | $9 | +34.8% |
| 2029 | $10 | +43.3% |
| 2030 | $10 | +48.2% |
| 2031 | — | +51.1% |
基于技术分析的股价预测
14 项技术面信号（SMA×6 + EMA×6 + RSI + MACD）· EEAT 方法论透明
Market Sentiment
BEARISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · PBYI · Jun 9, 2026
最新分析师评级与调整
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-02-28 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-12-23 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-11-08 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-08-02 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-07-26 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-06-04 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-06-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-20 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2024-05-03 | HC Wainwright & Co. | Maintains | Buy→Buy |
Wall Street analysts have recently issued updated ratings on Puma Biotechnology, Inc. (PBYI) stock. Of the recent 89 rating actions, 6 were upgrades and 11 were downgrades. 19 analysts currently cover PBYI.
分析师推荐趋势
PBYI analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 2 to 1 per month.
财务预测：EPS 与营收一致预期
Revenue This Year
$222M
↑ 2.8% YoY
Revenue Next Year
$219M
↓ 1.4% YoY
EPS This Year
$0.29
EPS Next Year
$0.20
↓ 31.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast PBYI EPS of $0.29 for the current fiscal year, based on estimates from 1 analysts. The PBYI revenue forecast is $222M for the current year. These are analyst consensus estimates via FMP / S&P Global.
关于预测与目标价
PBYI 股价预测由两类独立数据源支撑：来自 19 位华尔街分析师（S&P Global / FMP）的共识评级，以及基于历史日终价计算的技术分析。PBYI 的共识目标价为 $0.00（+0.0% 上行空间），分析师共识为 Buy。
PBYI 的短期预测（明日）为 $6.77（-1.16%）。 PBYI 对 2027 年的股价预测均值为 $8。 PBYI 对 2030 年的预测区间为 $10–$11。
Puma Biotechnology, Inc. 在 NASDAQ 上市，代码 PBYI。PBYI 在 2027 年的整体展望偏积极，在覆盖分析师中约 42% 对应 Buy 共识。
常见问题
PBYI 预测 · 8 个问题根据 19 位华尔街分析师，PBYI 的 12 个月平均目标价为 $0.00，最高 $0.00、最低 $0.00。若有图表，中位目标价可在上方查看。相对当前价 $6.85，隐含约 +0.0% 的上行空间。
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.